Altered expression of myeloperoxidase precursor, myeloid cell nuclear differentiation antigen, Fms-related tyrosine kinase 3 ligand, and antigen CD11A genes in leukocytes of clozapine-treated schizophrenic patients.
Lahdelma
Liisa
L
Jee
Kowan Ja
KJ
Joffe
Grigori
G
Tchoukhine
Evgueni
E
Oksanen
Jorma
J
Kaur
Sippy
S
Knuutila
Sakari
S
Andersson
Leif C
LC
D000328:Adult; D015214:Antigens, Differentiation, Myelomonocytic / Q000096:biosynthesis*; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D040881:CD11a Antigen / Q000096:biosynthesis*; D003024:Clozapine / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D007962:Leukocytes / Q000187:drug effects* / Q000378:metabolism*; D008297:Male; D009195:Peroxidase / Q000096:biosynthesis*; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D014157:Transcription Factors / Q000096:biosynthesis*; D051941:fms-Like Tyrosine Kinase 3 / Q000096:biosynthesis*
D015214:Antigens, Differentiation, Myelomonocytic; D014150:Antipsychotic Agents; D040881:CD11a Antigen; C075373:MNDA protein, human; D014157:Transcription Factors; D009195:Peroxidase; D051941:fms-Like Tyrosine Kinase 3; D003024:Clozapine